Literature DB >> 15970500

Genes related to estrogen action in reproduction and breast cancer.

Aninda Basu1, Brian G Rowan.   

Abstract

Estrogen is an important steroid hormone with diverse functions in different parts of the human body. The developmental and physiological role of estrogen is mediated by estrogen receptor alpha (ER-alpha) and newly identified ER-beta. Regulation of expression of various important cellular oncogenes and tumor suppressor genes is a key component of estrogen and ER action. The expression of these genes is crucial in various processes such as cell cycle progression, mammary gland development, growth factor pathways and apoptosis. A very precise and accurate control of these genes is required for normal growth and functioning of cells. Aberrant expression of these genes through elevated expression, gene amplification or mutation may lead to induction and/or progression of different cancers including estrogen-dependent breast cancers. This review briefly describes the role of different genes that are regulated by estrogen in female reproductive tissues and breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970500     DOI: 10.2741/1703

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

1.  17β-estradiol regulates the malignancy of cancer stem-like cells derived from the MCF7 cell line partially through Sox2.

Authors:  Lian Guo; Feng Li; Mengyuan Wang; Yue Xu; Bangqiong Wang; Dongchuan Ran; Xianxiang Zhang
Journal:  Oncol Lett       Date:  2018-01-15       Impact factor: 2.967

2.  Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial content.

Authors:  Rebecca E Nakles; Maddalena Tilli Shiffert; Edgar S Díaz-Cruz; M Carla Cabrera; Maram Alotaiby; Anne M Miermont; Anna T Riegel; Priscilla A Furth
Journal:  Mol Endocrinol       Date:  2011-02-03

3.  Androgens' effects to enhance learning may be mediated in part through actions at estrogen receptor-beta in the hippocampus.

Authors:  Kassandra L Edinger; Cheryl A Frye
Journal:  Neurobiol Learn Mem       Date:  2006-08-14       Impact factor: 2.877

4.  Heterogeneity of Bcl-2 expression in metastatic breast carcinoma.

Authors:  Andrea Proctor Subhawong; Hind Nassar; Marc K Halushka; Peter B Illei; Russell Vang; Pedram Argani
Journal:  Mod Pathol       Date:  2010-05-21       Impact factor: 7.842

5.  Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors.

Authors:  Gwen E Dressing; Rebecca Alyea; Yefei Pang; Peter Thomas
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

6.  Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway.

Authors:  Xiaojuan Wu; Limin Sun; Xiao Wang; Peng Su; Zhishuang Li; Chunyan Zhang; Yan Wang; Peng Gao; Rong Ma
Journal:  Pathol Oncol Res       Date:  2015-11-25       Impact factor: 3.201

7.  Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

Authors:  Emily M Fox; Teresa M Bernaciak; Jie Wen; Amanda M Weaver; Margaret A Shupnik; Corinne M Silva
Journal:  Mol Endocrinol       Date:  2008-06-11

8.  Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

Authors:  J Wen; R Li; Y Lu; M A Shupnik
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

9.  Suppression of GNAI2 message in ovarian cancer.

Authors:  John R Raymond; Kathryn M Appleton; Jennifer Y Pierce; Yuri K Peterson
Journal:  J Ovarian Res       Date:  2014-01-14       Impact factor: 4.234

10.  17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.

Authors:  Paul K Wright; Sarah Bowen Jones; Nicholas Ardern; Rebecca Ward; Robert B Clarke; Federica Sotgia; Michael P Lisanti; Goran Landberg; Rebecca Lamb
Journal:  Oncotarget       Date:  2014-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.